Intelligenome
  • Sign In
  • Create Account
  • My Account

  • Signed in as:

  • filler@godaddy.com

  • My Account

  • Sign out

  • HOME
  • ABOUT
    • Corporation
    • Executive Team
  • TECHNOLOGY
    • CRISPR
    • CRISPR-TB Benchtop Assay
    • CRISPR-TB Point of Care
    • Landmark Publications
  • APPLICATIONS
    • Tuberculosis (TB)
    • NTM
    • MAC
    • Oncology
  • PARTNERSHIPS
    • Clinical Diagnostics
    • Research Projects
    • Pharma Collaborations
    • Discovery Projects
  • CAREERS
  • CONTACT
  • More
    • HOME
    • ABOUT
      • Corporation
      • Executive Team
    • TECHNOLOGY
      • CRISPR
      • CRISPR-TB Benchtop Assay
      • CRISPR-TB Point of Care
      • Landmark Publications
    • APPLICATIONS
      • Tuberculosis (TB)
      • NTM
      • MAC
      • Oncology
    • PARTNERSHIPS
      • Clinical Diagnostics
      • Research Projects
      • Pharma Collaborations
      • Discovery Projects
    • CAREERS
    • CONTACT
Intelligenome

Signed in as:

filler@godaddy.com

  • HOME
  • ABOUT
    • Corporation
    • Executive Team
  • TECHNOLOGY
    • CRISPR
    • CRISPR-TB Benchtop Assay
    • CRISPR-TB Point of Care
    • Landmark Publications
  • APPLICATIONS
    • Tuberculosis (TB)
    • NTM
    • MAC
    • Oncology
  • PARTNERSHIPS
    • Clinical Diagnostics
    • Research Projects
    • Pharma Collaborations
    • Discovery Projects
  • CAREERS
  • CONTACT

Account

  • My Account

  • Sign out

  • Sign In
  • My Account

sales@intelligenome-us.com

Accelerating Disease Detection

Accelerating Disease DetectionAccelerating Disease DetectionAccelerating Disease Detection

Decentralized CRISPR Diagnostics at the Point-of-Care

Contact Us

sales@intelligenome-us.com

Accelerating Disease Detection

Accelerating Disease DetectionAccelerating Disease DetectionAccelerating Disease Detection

Decentralized CRISPR Diagnostics at the Point-of-Care

Contact Us

IntelliGenome's breakthrough CRISPR technology platform accurately and reliably detects pathogens early and 

quantitatively monitors response to treatment selection.

Technology

Pioneering research fuels breakthrough technologies.

Team

Established collaborations with public health agencies, universities and industry partners.

Collaborations

Our Technology

Breakthrough CRISPR Technology Platform

Ultra-sensitive, Rapid Test Results

High-throughput Platform

Subscribe

Sign up to hear from us.

Contact Us

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

sales@intelligenome-us.com

Copyright © 2024 IntelliGenome - All Rights Reserved.

Powered by GoDaddy

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept